4.4 Article

Greater Lateral Femorotibial Cartilage Loss in Osteoarthritis Initiative Participants With Incident Total Knee Arthroplasty: A Prospective Cohort Study

期刊

ARTHRITIS CARE & RESEARCH
卷 67, 期 10, 页码 1481-1486

出版社

WILEY
DOI: 10.1002/acr.22608

关键词

-

资金

  1. Osteoarthritis Initiative (OAI) - NIH, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]
  2. Pfizer
  3. Novartis Pharmaceuticals Corporation
  4. Merck Research Laboratories
  5. GlaxoSmithKline
  6. Foundation for the NIH
  7. Eli Lilly
  8. Merck Serono SA
  9. Wyeth Research
  10. Centocor Research and Development
  11. Novartis Pharma AG
  12. OAI coordinating center (University of California, San Francisco)
  13. NIH
  14. Novartis
  15. Merck Serono
  16. GlaxoSmithKlein
  17. Wyeth
  18. Centocor
  19. Mariel Therapeutics
  20. Stryker
  21. Abbvie
  22. Kolon
  23. Synarc
  24. BICL
  25. Ampio

向作者/读者索取更多资源

Objective. To explore whether baseline to 12-month followup change in femorotibial cartilage thickness differs between subjects who received a total knee arthroplasty (TKA) between 24 and 60 months from those without TKA (non-TKA). Methods. In this prospective cohort study, 531 right knees from Osteoarthritis Initiative participants with definite radiographic knee osteoarthritis (Kellgren/Lawrence [K/L] grades 2-4) were studied. Segmentation was applied to coronal fast low-angle shot magnetic resonance images, to quantitatively determine cartilage thickness in 16 femorotibial subregions. Unadjusted P values (t-tests) and P values adjusted for age, baseline body mass index (BMI), K/L grade, and sex (generalized estimating equation models) were used to evaluate differences in longitudinal 1-year rates of cartilage thickness between TKAs and non-TKAs, with total knee arthroplasty status as fixed effect. Results. Of the 531 participants (mean +/- SD ages 63 +/- 9 years, BMI 30 +/- 4.8 kg/m(2)), 40 received a femorotibial TKA within 4 years. At baseline, TKAs had thinner medial and lateral femorotibial cartilage (215%; P < 0.001) than non-TKAs. Longitudinal cartilage thickness change was significantly greater in TKAs than in non-TKAs in the total femorotibial joint (area under the curve [AUC] 0.64), the lateral compartment (AUC 0.66), both tibiae (AUC >= 0.61), and the first 9 (of 16) ordered values of subregion change (AUC 0.64-0.69). Discrimination was stronger for TKAs that occurred at 24 and 36 months (n=18) than for those at 48 and 60 months (n=22). Conclusion. Knees with incident TKA displayed smaller baseline cartilage thickness and greater lateral as well as location-independent ordered value femorotibial cartilage loss than non-TKAs. Discrimination of cartilage loss was greater for TKAs occurring within 2 years after the measurement than for those occurring later.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据